A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers

The standard therapy for locally advanced rectal cancers (LARCs) is neoadjuvant chemoradiation (nCRT) followed by surgical resection. Pathological response to nCRT varies among patients, and it remains a challenge to predict pathological response to nCRT in LARCs.

http://ift.tt/2DZhZnj